A detailed history of Schonfeld Strategic Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 22 shares of AMGN stock, worth $6,333. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22
Holding current value
$6,333
% of portfolio
0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $6,806 - $7,422
22 New
22 $7,000
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $8.56 Million - $10.3 Million
-31,837 Reduced 98.97%
332 $94,000
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $8.02 Million - $9.04 Million
-31,352 Reduced 49.36%
32,169 $9.27 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $13.9 Million - $17.2 Million
63,521 New
63,521 $17.1 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $2.15 Million - $2.62 Million
-9,536 Reduced 30.69%
21,535 $5.21 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $19.9 Million - $25.3 Million
-86,995 Reduced 73.68%
31,071 $8.16 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $3.15 Million - $3.55 Million
-14,038 Reduced 10.63%
118,066 $26.6 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $16.1 Million - $17.9 Million
69,802 Added 112.04%
132,104 $32.1 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $13.7 Million - $15.1 Million
62,302 New
62,302 $15.1 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $289,370 - $331,158
-1,455 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$212.27 - $248.7 $308,852 - $361,858
1,455 New
1,455 $309,000
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $496,591 - $550,931
-2,126 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $471,780 - $549,783
2,126 New
2,126 $528,000
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $3.4 Million - $4.05 Million
-15,713 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $3.69 Million - $4.1 Million
15,713 New
15,713 $4,000
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $939,399 - $1.15 Million
-4,749 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $865,457 - $1.15 Million
4,749 New
4,749 $963,000
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $6.03 Million - $7.74 Million
-31,843 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $4.52 Million - $5.41 Million
25,945 Added 439.89%
31,843 $6.16 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $283,890 - $332,783
-1,703 Reduced 22.4%
5,898 $1.09 Million
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $837,970 - $944,576
-4,633 Reduced 37.87%
7,601 $1.44 Million
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $1.83 Million - $2.14 Million
10,253 Added 517.57%
12,234 $2.38 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $367,059 - $413,811
1,981 New
1,981 $411,000
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $336,915 - $378,428
-2,029 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $7.28 Million - $8.51 Million
-42,971 Reduced 95.49%
2,029 $346,000
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $4.22 Million - $4.71 Million
25,000 Added 125.0%
45,000 $7.83 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $3.35 Million - $3.82 Million
20,000
20,000 $3.73 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.